Annual Non Current Assets
$17.96 M
-$417.00 K-2.27%
31 December 2023
Summary:
Rigel Pharmaceuticals annual long term assets is currently $17.96 million, with the most recent change of -$417.00 thousand (-2.27%) on 31 December 2023. During the last 3 years, it has fallen by -$3.44 million (-16.06%). RIGL annual non current assets is now -37.13% below its all-time high of $28.56 million, reached on 31 December 2019.RIGL Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$32.95 M
-$733.00 K-2.18%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly long term assets is currently $32.95 million, with the most recent change of -$733.00 thousand (-2.18%) on 30 September 2024. Over the past year, it has increased by +$12.65 million (+62.33%). RIGL quarterly non current assets is now -3.18% below its all-time high of $34.03 million, reached on 31 March 2024.RIGL Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.3% | +62.3% |
| 3 y3 years | -16.1% | +113.8% |
| 5 y5 years | +746.3% | +9.6% |
RIGL Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.1% | +39.6% | -3.2% | +537.5% |
| 5 y | 5 years | -37.1% | +746.3% | -3.2% | +537.5% |
| alltime | all time | -37.1% | +970.3% | -3.2% | +1863.8% |
Rigel Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $32.95 M(-2.2%) |
| June 2024 | - | $33.69 M(-1.0%) |
| Mar 2024 | - | $34.03 M(+89.5%) |
| Dec 2023 | $99.27 M(-14.4%) | $17.96 M(-11.5%) |
| Sept 2023 | - | $20.30 M(+25.6%) |
| June 2023 | - | $16.17 M(-2.8%) |
| Mar 2023 | - | $16.64 M(-9.4%) |
| Dec 2022 | $115.90 M(-25.0%) | $18.38 M(+255.5%) |
| Sept 2022 | - | $5.17 M(-30.9%) |
| June 2022 | - | $7.48 M(-26.2%) |
| Mar 2022 | - | $10.14 M(-21.2%) |
| Dec 2021 | $154.47 M(+73.6%) | $12.86 M(-16.6%) |
| Sept 2021 | - | $15.41 M(-11.4%) |
| June 2021 | - | $17.40 M(-9.5%) |
| Mar 2021 | - | $19.23 M(-10.1%) |
| Dec 2020 | $88.98 M(-25.2%) | $21.39 M(-7.8%) |
| Sept 2020 | - | $23.21 M(-7.0%) |
| June 2020 | - | $24.95 M(-7.7%) |
| Mar 2020 | - | $27.03 M(-5.4%) |
| Dec 2019 | $119.00 M(-13.1%) | $28.56 M(-5.0%) |
| Sept 2019 | - | $30.06 M(-5.0%) |
| June 2019 | - | $31.65 M(-5.4%) |
| Mar 2019 | - | $33.47 M(+1477.0%) |
| Dec 2018 | $136.99 M(+16.7%) | $2.12 M(-0.5%) |
| Sept 2018 | - | $2.13 M(-1.3%) |
| June 2018 | - | $2.16 M(-1.4%) |
| Mar 2018 | - | $2.19 M(+30.7%) |
| Dec 2017 | $117.43 M(+54.1%) | $1.68 M(-0.7%) |
| Sept 2017 | - | $1.69 M(+0.2%) |
| June 2017 | - | $1.69 M(-6.4%) |
| Mar 2017 | - | $1.80 M(-6.1%) |
| Dec 2016 | $76.21 M(-40.9%) | $1.92 M(-8.3%) |
| Sept 2016 | - | $2.09 M(-13.6%) |
| June 2016 | - | $2.42 M(-9.4%) |
| Mar 2016 | - | $2.67 M(-1.8%) |
| Dec 2015 | $129.02 M(-14.3%) | $2.72 M(-8.9%) |
| Sept 2015 | - | $2.99 M(+5.6%) |
| June 2015 | - | $2.83 M(-10.6%) |
| Mar 2015 | - | $3.17 M(-12.0%) |
| Dec 2014 | $150.54 M(-31.6%) | $3.60 M(-15.9%) |
| Sept 2014 | - | $4.28 M(-12.6%) |
| June 2014 | - | $4.89 M(-10.5%) |
| Mar 2014 | - | $5.46 M(-8.7%) |
| Dec 2013 | $220.07 M(-27.2%) | $5.98 M(-8.3%) |
| Sept 2013 | - | $6.52 M(-8.1%) |
| June 2013 | - | $7.10 M(-5.8%) |
| Mar 2013 | - | $7.53 M(-0.7%) |
| Dec 2012 | $302.46 M | $7.58 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $7.69 M(-3.8%) |
| June 2012 | - | $7.99 M(+1.9%) |
| Mar 2012 | - | $7.84 M(+14.0%) |
| Dec 2011 | $250.23 M(+39.1%) | $6.87 M(-5.5%) |
| Sept 2011 | - | $7.27 M(-0.3%) |
| June 2011 | - | $7.30 M(+0.8%) |
| Mar 2011 | - | $7.24 M(+6.9%) |
| Dec 2010 | $179.93 M(+32.3%) | $6.77 M(+16.7%) |
| June 2010 | - | $5.80 M(+19.5%) |
| Mar 2010 | - | $4.85 M(+1.6%) |
| Dec 2009 | $135.97 M(-1.5%) | $4.78 M(-7.3%) |
| Sept 2009 | - | $5.15 M(-8.7%) |
| June 2009 | - | $5.64 M(-6.4%) |
| Mar 2009 | - | $6.03 M(+4.5%) |
| Dec 2008 | $138.09 M(+24.3%) | $5.77 M(+11.4%) |
| Sept 2008 | - | $5.18 M(+1.5%) |
| June 2008 | - | $5.11 M(+11.6%) |
| Mar 2008 | - | $4.58 M(-1.8%) |
| Dec 2007 | $111.13 M(+2.9%) | $4.66 M(-6.2%) |
| Sept 2007 | - | $4.97 M(-3.0%) |
| June 2007 | - | $5.12 M(-3.5%) |
| Mar 2007 | - | $5.31 M(+1.6%) |
| Dec 2006 | $108.01 M(-24.3%) | $5.23 M(-4.1%) |
| Sept 2006 | - | $5.45 M(+11.3%) |
| June 2006 | - | $4.90 M(-3.3%) |
| Mar 2006 | - | $5.07 M(-0.1%) |
| Dec 2005 | $142.60 M(+92.1%) | $5.07 M(+17.4%) |
| Sept 2005 | - | $4.32 M(-3.3%) |
| June 2005 | - | $4.47 M(-5.2%) |
| Mar 2005 | - | $4.71 M(+2.8%) |
| Dec 2004 | $74.24 M(+48.1%) | $4.58 M(+0.6%) |
| Sept 2004 | - | $4.55 M(+1.2%) |
| June 2004 | - | $4.50 M(-6.9%) |
| Mar 2004 | - | $4.83 M(-10.7%) |
| Dec 2003 | $50.11 M(+35.9%) | $5.41 M(-10.2%) |
| Sept 2003 | - | $6.03 M(-9.4%) |
| June 2003 | - | $6.65 M(-4.9%) |
| Mar 2003 | - | $7.00 M(-6.5%) |
| Dec 2002 | $36.86 M(+0.9%) | $7.48 M(-48.3%) |
| Sept 2002 | - | $14.48 M(+29.3%) |
| June 2002 | - | $11.19 M(+6.7%) |
| Mar 2002 | - | $10.49 M(+5.8%) |
| Dec 2001 | $36.53 M(-33.2%) | $9.91 M(-5.6%) |
| Sept 2001 | - | $10.51 M(-4.9%) |
| June 2001 | - | $11.05 M(+9.7%) |
| Mar 2001 | - | $10.08 M(+5.2%) |
| Dec 2000 | $54.68 M(+541.1%) | $9.58 M |
| Dec 1999 | $8.53 M | - |
FAQ
- What is Rigel Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual non current assets year-on-year change?
- What is Rigel Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly non current assets year-on-year change?
What is Rigel Pharmaceuticals annual long term assets?
The current annual non current assets of RIGL is $17.96 M
What is the all time high annual non current assets for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual long term assets is $28.56 M
What is Rigel Pharmaceuticals annual non current assets year-on-year change?
Over the past year, RIGL annual long term assets has changed by -$417.00 K (-2.27%)
What is Rigel Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of RIGL is $32.95 M
What is the all time high quarterly non current assets for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly long term assets is $34.03 M
What is Rigel Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, RIGL quarterly long term assets has changed by +$12.65 M (+62.33%)